$SERA SEC Filings

Filed On	Filing
13 Oct 2026	Form 4: Inglis Tiffany Eul Davis, Chief Medical Officer Sold 8,024 shares ($16.3K)
13 Oct 2026	144
11 Sep 2026	Form 4: Inglis Tiffany Eul Davis, Chief Medical Officer Sold 486 shares ($972)
11 Sep 2026	144
11 Sep 2026	Form 4: Anderson Dyaarl Lee Jr., Chief Commercial Officer Sold 1,800 shares ($3.6K)
11 Sep 2026	144
11 Sep 2026	144
11 Sep 2026	Form 4: Lindgardt Zhenya, Director Sold 7,022 shares ($14K)
11 Sep 2026	144
11 Sep 2026	Form 4: Jackson Benjamin, General Counsel Sold 2,190 shares ($4.38K)
11 Sep 2026	144
09 Sep 2026	144
09 Sep 2026	Form 4: Lindgardt Zhenya, Director Sold 20,139 shares ($40.3K)
09 Sep 2026	144
02 Sep 2026	Form 4: Aerts Austin, Chief Financial Officer
01 Sep 2026	Form 4: Gleason Scott, Chief Financial Officer Received 117,924 shares as a grant or award · Granted 169,624 Stock Option (right to buy)
01 Sep 2026	Form 3: Gleason Scott, Chief Financial Officer No securities owned
19 Aug 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
12 Aug 2026	10-Q
12 Aug 2026	8-K: Results of Operations and Financial Condition

Comments